By proceeding, you agree to our Terms of Use and Privacy Policy.
Asimov builds tools to program living cells. By integrating mammalian synthetic biology, computer-aided design, and machine learning, our multi-disciplinary team is advancing the design and manufacture of biologics and gene therapies.
20-22 September 2022
The Newly Re-Branded 13th World Multispecifics Summit is the Only End-to-End Meeting Committed Solely to Advancing the Development of Bi- & Multi-Specific Therapeutics With more clinical candidates and commercial success than ever within this rapidly
Event Ended
USA
Paid
Boston
11-13 October 2022
The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures.
Hybrid
Carlsbad
14-16 November 2022
Network with more than 1,000 colleagues at PEGS Europe, the largest protein & antibody engineering event in Europe, which has been described as "the best biologics technology meeting in Europe.
Spain
Barcelona
17-20 January 2023
January 17th – 20th 2023 I Miami Beach Convention Center Advanced Therapies Week is the destination to form partnerships, by day, and by night. Advanced Therapies Week is an event like no other.
Miami Beach
27-02 March 2023
The BPI US West 2023 scientific agenda covers today's latest innovations across all phases of biopharmaceutical development and manufacturing. Your registration provides access to all 6 conference tracks and includes 12 months of on demand access to
San Diego
14-15 August 2023
Advances in host cell engineering, better expression of cell lines and optimization of cell culture processes, have greatly accelerated upstream processing in the last decade, resulting in today's antibody production yield of 10g/L or more. Meanwhile
Vaccines and mRNA-based vaccines have recently gained a lot of attention due to COVID-19. Cambridge Healthtech Institute’s 3rd Annual Vaccine Development and Manufacturing conference tackles the practical challenges facing the development, manufactur
Cambridge Healthtech Institute’s Gene Therapy CMC and Analytics conference uncovers the practical challenges facing the analysis, characterization, and quality of viral vector-based gene therapies for clinical and commercial supply, with dedicated se
The popular 11th Annual Rapid Methods to Assess Stability and Impurities in Biologics conference will bring together experts in formulation, analytical sciences, and process to discuss rapid and practical ways to accelerate prediction and screening f
Cambridge Healthtech Institute’s Cell Therapy CMC and Analytics conference focuses on the characterization, control, and quality of cell-based therapies, supported by in-depth case studies and insight from leading industry and academic representative
The biopharma industry is driven by the need to increase productivity, reduce cost, while maintaining product quality and consistency. Continuous biomanufacturing and process intensification are borne out of such need. CHI’s Intensified & Continuous
Characterizing and controlling process-related impurities, such as host cell proteins (HCPs), is a critical part of bioprocessing, with regulators now pressing companies for more data and questions emerging on the role of HCPs in emerging modalities.
14-17 August 2023
The Bioprocessing Summit 2023, now in its fifteenth year, stands as the premier global forum for industry leaders to converge and exchange groundbreaking advancements in bioprocess research and development, scale-up, quality, and analytics. This high
16-17 August 2023
The approval of COVID-19 vaccines was the breakthrough for mRNA-based technology, and it opened so many opportunities for mRNA-based vaccines and therapeutics. CHI’s 2nd Annual mRNA-Based Therapies conference will explore the technical challenges fac
Pharmaceutical companies today are increasingly harnessing the power of digitalization to drive scientific and operational excellence across the value chain, from R&D to manufacturing. Digitalization is a key enabler to smarter bioprocessing and to h
Industry analytical groups are facing increased pressure to deliver key studies faster than ever before – and at lower costs. Cambridge Healthtech Institute’s 10th Annual Accelerating Analytical Development conference offers a best practices forum in
Newer and more complex molecules coming down the pipeline are bringing a new set of challenges to the downstream process development team, leading to the search for innovative technologies to meet the demand for higher yield while maintaining product
The development of high-concentration protein formulations for traditional and novel biologic products can be challenging during manufacturing, storage, and delivery due to problems such as aggregation, precipitation, gelation, and high viscosity. Th
Cambridge Healthtech Institute’s Gene Therapy Manufacturing conference discusses the practical challenges facing the production, purification, and manufacturing of viral and non-vector-based gene therapies. Topics include: AAV and lentivirus upstream
CHI’s Cell Therapy Manufacturing conference examines the practical challenges in manufacturing autologous and allogenic cell therapies at scale, with dedicated sessions on cell processing, scalability, next-generation production technologies, automat
18-21 September 2023
The Largest Bioprocessing Event is an annual conference held at the Boston Convention and Exhibition Center, focusing on accelerating the development and commercial success of promising biologics, cell therapies, and gene therapies. The event brings
13-16 December 2023
The latest science and research on antibody engineering, design and selection diving into critical topics including Neurodegenerative Diseases, Tumor Microenvironment in Antibody Therapy, Antibody Immune Agonist, Bi-Specifics, ADCs, Protein-Based Deg